About
Eric Schuur, PhD is a biotechnology executive focused on liver disease and regenerative medicine. HepaTx lists him as co-founder and CEO, with prior scientific and industry experience spanning UCLA, Stanford, Scripps, Calydon, and Asthmatx. Public sources also show him serving as an adviser to Stanford SPARK and a mentor in Stanford's Innovation Farm Team Program.
Areas of interest
biotechregenerative medicinecell therapygene therapygenomicsdiagnosticsbiomarkersliver diseasetranslational medicine